Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00681369

Enrollment

217

Registered

2008-05-21

Start date

2007-05-31

Completion date

2007-06-30

Last updated

2011-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, fulvestrant, longitudinal study, France

Brief summary

the purpose of this study is to describe the way Faslodex is used in France, in patients suffering from initial breast cancer, that is to evaluate Faslodex treatment duration and to determine patients profile

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007

Design outcomes

Primary

Measure	Time frame
Evaluate Faslodex therapeutic strategy and treatment duration	At the end of the study
Describe the characteristics of patients treated with Faslodex	At the end of the study

Outcome results